Research Site

Parktown 2193

1 studies enrolling now · 10 studies all time

What they study most

Asthma, Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus, Non-Insulin-Dependent, High Risk for Cardiovascular Event, Locally Advanced Cervical Cancer, Non Small Cell Lung Cancer NSCLC, Non-Small Cell Lung Cancer, RSV Infection, Scleroderma, Systemic Sclerosis, Type 2 Diabetes Mellitus, Viral Lung Infection and Acute Respiratory Failure

Studies at this site

• Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen — Recruiting now
• A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC — Recruiting now
• Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) — Running, not enrolling
• Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). — Running, not enrolling
• Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) — Completed
• Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children — Completed
• A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma — Completed
• Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events — Completed
• Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus — Completed
• This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC. — Completed